News articles about Imperva (NASDAQ:IMPV) have been trending somewhat positive this week, Accern Sentiment reports. Accern rates the sentiment of media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Imperva earned a media sentiment score of 0.18 on Accern’s scale. Accern also assigned news articles about the software maker an impact score of 44.0058553253566 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
IMPV stock traded down $0.55 during trading hours on Friday, reaching $46.15. 770,202 shares of the company’s stock traded hands, compared to its average volume of 441,703. The firm has a market cap of $1,606.30, a price-to-earnings ratio of 67.87 and a beta of 1.65. Imperva has a 12 month low of $37.17 and a 12 month high of $52.40.
Imperva (NASDAQ:IMPV) last posted its earnings results on Thursday, February 8th. The software maker reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.13. The company had revenue of $91.10 million for the quarter, compared to analyst estimates of $91.11 million. Imperva had a net margin of 7.11% and a negative return on equity of 3.28%. Imperva’s revenue was up 16.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.32 EPS. analysts forecast that Imperva will post -0.17 EPS for the current fiscal year.
In other news, CRO Michael D. Mooney sold 24,454 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $47.18, for a total value of $1,153,739.72. Following the sale, the executive now directly owns 24,454 shares of the company’s stock, valued at approximately $1,153,739.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Anthony J. Bettencourt sold 66,037 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $46.98, for a total transaction of $3,102,418.26. Following the completion of the sale, the director now directly owns 66,037 shares in the company, valued at $3,102,418.26. The disclosure for this sale can be found here. Insiders own 1.90% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by BBNS and is owned by of BBNS. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://baseballnewssource.com/2018/03/18/somewhat-favorable-media-coverage-somewhat-unlikely-to-impact-imperva-impv-share-price/2006065.html.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.